Latest Birchview Capital, LP Stock Portfolio
Birchview Capital, LP Performance:
2025 Q3: 16.18%YTD: -1.14%2024: 2.17%
Performance for 2025 Q3 is 16.18%, and YTD is -1.14%, and 2024 is 2.17%.
About Birchview Capital, LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Birchview Capital, LP reported an equity portfolio of $132.4 Millions as of 30 Sep, 2025.
The top stock holdings of Birchview Capital, LP are KLAC, BMY, CORT. The fund has invested 17.8% of it's portfolio in KLA CORPORATION and 10.8% of portfolio in BRISTOL-MYERS SQUIBB CO.
The fund managers got completely rid off XENCOR INC (XNCR), MOONLAKE IMMUNOTHERAPEUTICS (MLTX) and BIOCRYST PHARMACEUTICALS INC (BCRX) stocks. They significantly reduced their stock positions in TRAVERE THERAPEUTICS INC (TVTX), ELUTIA INC (AZYO) and ORTHOPEDIATRICS CORP (KIDS). Birchview Capital, LP opened new stock positions in COMPASS THERAPEUTICS INC (CMPX), BICYCLE THERAPEUTICS PLC (BCYC) and VOYAGER THERAPEUTICS INC (VYGR). The fund showed a lot of confidence in some stocks as they added substantially to AMICUS THERAPEUTICS INC (FOLD), VENTYX BIOSCIENCES INC (VTYX) and PHATHOM PHARMACEUTICALS INC (PHAT).
The top stock holdings of Birchview Capital, LP are KLAC, BMY, CORT. The fund has invested 17.8% of it's portfolio in KLA CORPORATION and 10.8% of portfolio in BRISTOL-MYERS SQUIBB CO.
The fund managers got completely rid off XENCOR INC (XNCR), MOONLAKE IMMUNOTHERAPEUTICS (MLTX) and BIOCRYST PHARMACEUTICALS INC (BCRX) stocks. They significantly reduced their stock positions in TRAVERE THERAPEUTICS INC (TVTX), ELUTIA INC (AZYO) and ORTHOPEDIATRICS CORP (KIDS). Birchview Capital, LP opened new stock positions in COMPASS THERAPEUTICS INC (CMPX), BICYCLE THERAPEUTICS PLC (BCYC) and VOYAGER THERAPEUTICS INC (VYGR). The fund showed a lot of confidence in some stocks as they added substantially to AMICUS THERAPEUTICS INC (FOLD), VENTYX BIOSCIENCES INC (VTYX) and PHATHOM PHARMACEUTICALS INC (PHAT).
Birchview Capital, LP Annual Return Estimates Vs S&P 500
Our best estimate is that Birchview Capital, LP made a return of 16.18% in the last quarter. In trailing 12 months, it's portfolio return was 1.43%.
New Buys
| Ticker | $ Bought |
|---|---|
| compass therapeutics inc | 3,055,280 |
| bicycle therapeutics plc | 1,191,960 |
| voyager therapeutics inc | 630,067 |
| avalo therapeutics inc | 394,010 |
| guardant health inc | 374,880 |
| pharvaris n v | 370,433 |
| nektar therapeutics | 228,795 |
| healthcare select sector spdr fund | 208,477 |
New stocks bought by Birchview Capital, LP
Additions
| Ticker | % Inc. |
|---|---|
| amicus therapeutics inc | 803 |
| ventyx biosciences inc | 243 |
| phathom pharmaceuticals inc | 240 |
| cytokinetics inc | 200 |
| outset medical inc | 127 |
| structure therapeutics inc | 116 |
| immunome inc | 75.00 |
| bridgebio pharma inc | 73.76 |
Additions to existing portfolio by Birchview Capital, LP
Reductions
| Ticker | % Reduced |
|---|---|
| travere therapeutics inc | -58.19 |
| elutia inc | -38.64 |
| orthopediatrics corp | -38.46 |
| harrow health inc | -33.33 |
| united therapeutics corp | -29.41 |
| axogen inc | -26.04 |
| uniqure nv | -20.23 |
| applied therapeutics inc | -19.64 |
Birchview Capital, LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| accelerate diagnostics inc | -2,082 |
| xencor inc | -550,200 |
| wave life sciences ltd | -261,950 |
| biocryst pharmaceuticals inc | -358,400 |
| cogent biosciences inc | -287,200 |
| 10x genomics inc | -254,760 |
| neuropace inc | -183,164 |
| aptevo therapeutics inc | -30,500 |
Birchview Capital, LP got rid off the above stocks
Sector Distribution
Birchview Capital, LP has about 72.7% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 72.7 |
| Technology | 17.8 |
| Energy | 4.7 |
| Others | 4.2 |
Market Cap. Distribution
Birchview Capital, LP has about 37.8% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 37.8 |
| SMALL-CAP | 29.9 |
| MID-CAP | 20.7 |
| MICRO-CAP | 7.1 |
| UNALLOCATED | 3.7 |
Stocks belong to which Index?
About 74.3% of the stocks held by Birchview Capital, LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 43.7 |
| S&P 500 | 30.6 |
| Others | 25.8 |
Birchview Capital, LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Birchview Capital, LP
Birchview Capital, LP has 69 stocks in it's portfolio. About 55.5% of the portfolio is in top 10 stocks. PHR proved to be the most loss making stock for the portfolio. QURE was the most profitable stock for Birchview Capital, LP last quarter.
Last Reported on: 13 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACAD | acadia pharmaceuticals inc | 2.76 | 171,000 | 3,649,140 | reduced | -8.95 | ||
| ALKS | alkermes plc | 1.13 | 50,000 | 1,500,000 | unchanged | 0.00 | ||
| APLS | apellis pharmaceuticals inc | 0.24 | 14,000 | 316,820 | unchanged | 0.00 | ||
| APLT | applied therapeutics inc | 0.10 | 225,000 | 136,103 | reduced | -19.64 | ||
| APVO | aptevo therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ATEC | alphatec holdings inc | 0.36 | 33,000 | 479,820 | unchanged | 0.00 | ||
| AVTX | avalo therapeutics inc | 0.30 | 31,000 | 394,010 | new | |||
| AXDX | accelerate diagnostics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AXGN | axogen inc | 1.60 | 119,078 | 2,124,350 | reduced | -26.04 | ||
| AXSM | axsome therapeutics inc | 0.55 | 6,000 | 728,700 | unchanged | 0.00 | ||
| AZYO | elutia inc | 0.48 | 711,175 | 633,088 | reduced | -38.64 | ||
| BBIO | bridgebio pharma inc | 0.34 | 8,688 | 451,255 | added | 73.76 | ||
| BCRX | biocryst pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BCYC | bicycle therapeutics plc | 0.90 | 154,000 | 1,191,960 | new | |||
| BDSX | biodesix inc | 1.64 | 286,804 | 2,165,370 | reduced | 0.00 | ||
| BMY | bristol-myers squibb co | 10.79 | 316,842 | 14,289,600 | reduced | -2.02 | ||
| BPMC | blueprint medicines corp | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CADL | candel therapeutics inc | 0.23 | 60,000 | 306,000 | unchanged | 0.00 | ||
| CGEM | cullinan therapeutics inc | 0.09 | 20,000 | 118,600 | unchanged | 0.00 | ||
| CMPX | compass therapeutics inc | 2.31 | 872,938 | 3,055,280 | new | |||